Challenges in developing evidence-based recommendations using the GRADE approach: the case of mental, neurological, and substance use disorders.

Challenges in developing evidence-based recommendations using the GRADE approach: the case of mental, neurological, and substance use disorders.

Bibliographic Details
Main Authors:	Corrado Barbui, Tarun Dua, Mark van Ommeren, M Taghi Yasamy, Alexandra Fleischmann, Nicolas Clark, Graham Thornicroft, Suzanne Hill, Shekhar Saxena
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2010-08-01
Series:	PLoS Medicine
Online Access:	http://europepmc.org/articles/PMC2930877?pdf=render

Similar Items

Evidence-based guidelines for mental, neurological, and substance use disorders in low- and middle-income countries: summary of WHO recommendations.
by: Tarun Dua, et al.
Published: (2011-11-01)

Gaps and challenges: WHO treatment recommendations for tobacco cessation and management of substance use disorders in people with severe mental illness
by: Jayati Das-Munshi, et al.
Published: (2020-05-01)

Correction to: Gaps and challenges: WHO treatment recommendations for tobacco cessation and management of substance use disorders in people with severe mental illness
by: Jayati Das-Munshi, et al.
Published: (2020-06-01)

Non-specialist psychosocial interventions for children and adolescents with intellectual disability or lower-functioning autism spectrum disorders: a systematic review.
by: Brian Reichow, et al.
Published: (2013-12-01)

If you could only choose five psychotropic medicines: updating the interagency emergency health kit.
by: Mark van Ommeren, et al.
Published: (2011-05-01)

Packages of care for mental, neurological, and substance use disorders in low- and middle-income countries: PLoS Medicine Series.
by: Vikram Patel, et al.
Published: (2009-10-01)

Prevention and management of physical health conditions in adults with severe mental disorders: WHO recommendations
by: Petra C. Gronholm, et al.
Published: (2021-03-01)

Responsible governance for mental health research in low resource countries.
by: M Taghi Yasamy, et al.
Published: (2011-11-01)

Republished: Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition
by: Vikram Patel, et al.
Published: (2016-01-01)

Roadmap to strengthen global mental health systems to tackle the impact of the COVID-19 pandemic
by: Pallab K. Maulik, et al.
Published: (2020-07-01)

Disease burden and government spending on mental, neurological, and substance use disorders, and self-harm: cross-sectional, ecological study of health system response in the Americas
by: Daniel V Vigo, DrPH, et al.
Published: (2019-02-01)

The Impact and Burden of Neurological Sequelae Following Bacterial Meningitis: A Narrative Review
by: Nicoline Schiess, et al.
Published: (2021-04-01)

Exercise in the Treatment of Youth Substance Use Disorders: Review and Recommendations
by: Alissa More, et al.
Published: (2017-10-01)

The core competencies for mental, neurological, and substance use disorder care in sub-Saharan Africa
by: Pamela Y. Collins, et al.
Published: (2015-03-01)

Mental, neurologic, and substance use (MNS) disorders among street homeless people in Ethiopia
by: Getinet Ayano, et al.
Published: (2017-11-01)

Development of expert recommendations for the treatment of PTSD with comorbid substance use disorder
by: Neil P. Roberts
Published: (2021-02-01)

Evolution of substance use, neurological and psychiatric symptoms in schizophrenia and substance use disorder patients: a 12-week, pilot, case-control trial with quetiapine
by: Simon eZhornitsky, et al.
Published: (2011-05-01)

Intravenous high-dose immunotherapy: practical recommendations for use in the treatment of neurological disimmune diseases
by: N. A. Suponeva, et al.
Published: (2015-12-01)

Psychiatric and neurological symptoms in schizophrenia and substance use disorder patients treated for 12-weeks with quetiapine
by: Zhornitsky, Simon
Published: (2012)

Psychiatric and neurological symptoms in schizophrenia and substance use disorder patients treated for 12-weeks with quetiapine
by: Zhornitsky, Simon
Published: (2012)

Treatment of vascular dementia Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology
by: Sonia Maria Dozzi Brucki, et al.

Using the needs of WHO to prioritise Cochrane reviews: The case of antipsychotic drugs
by: Barbui Corrado, et al.
Published: (2011-09-01)

Six rapid assessments of alcohol and other substance use in populations displaced by conflict
by: Adelekan Moruf, et al.
Published: (2011-02-01)

Criteria for the diagnosis of Alzheimer's disease: Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology
by: Norberto Anízio Ferreira Frota, et al.

The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010.
by: Harvey A Whiteford, et al.
Published: (2015-01-01)

Role of Extracellular Vesicles in Substance Abuse and HIV-Related Neurological Pathologies
by: Katherine E. Odegaard, et al.
Published: (2020-09-01)

Executive function and future orientation moderate the relationship among substance use associations and outcome expectancies with substance use in adolescents : a pilot study
by: Barkowsky, Deborah Suzanne
Published: (2013)

Executive function and future orientation moderate the relationship among substance use associations and outcome expectancies with substance use in adolescents : a pilot study
by: Barkowsky, Deborah Suzanne
Published: (2013)

A new approach to psychiatric drug approval in Europe.
by: Corrado Barbui, et al.
Published: (2013-10-01)

Geneva calling: WHO resolution on mental disorders
by: Barbui Corrado, et al.
Published: (2012-06-01)

A United Nations General Assembly Special Session for mental, neurological, and substance use disorders: the time has come.
by: Judith K Bass, et al.
Published: (2012-01-01)

USE OF ACTOVEGIN IN NEUROLOGY
by: Yu. A. Starchina
Published: (2009-03-01)

Neurological uses of cannabis
by: Pushpendra Nath Renjen, et al.
Published: (2019-01-01)

Problematic substance use or problematic substance use policies?
by: Stockwell, Tim, et al.
Published: (2020-06-01)

Priority mental, neurological and substance use disorders in rural Kenya: Traditional health practitioners' and primary health care workers' perspectives.
by: Mary A Bitta, et al.
Published: (2019-01-01)

mhGAP Intervention guide for mental, neurological and substance use disorders in non-specialized health settings: version 2.0
by: Carmen Lucia Albuquerque de Santana

Clinimetric properties of lower limb neurological impairment tests for children and young people with a neurological condition: A systematic review.
by: Ramona Clark, et al.
Published: (2017-01-01)

People with severe mental illness as the perpetrators and victims of violence: time for a new public health approach
by: Graham Thornicroft
Published: (2020-02-01)

Recommendations for Haemodynamic and Neurological Monitoring in Repair of Acute Type A Aortic Dissection
by: Deborah K. Harrington, et al.
Published: (2011-01-01)

Recommendations of the Spanish Society of Neurology for the prevention of stroke. Interventions on lifestyle and air pollution
by: A. García Pastor, et al.
Published: (2021-06-01)

Cannot write session to /tmp/vufind_sessions/sess_6jingh41pi53a3svqb6lebp1ba